American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

New NIH Genetics Reference Can Help Your Patients

By News Staff

Family physicians now have a new resource they can offer patients who are concerned about their risks for specific genetically mediated conditions or who simply have questions about the science of genetics. In partnership with the AAFP and several other associations, NIH's National Library of Medicine has launched Genetics Home Reference, a free, patient-friendly Web site that includes entries on more than 500 topics related to genetic conditions and the genes associated with those conditions.

According to an NIH press release, information on the site may prove particularly helpful to new parents concerned about the genetic screening their infants undergo, a process that is required in all states, although not always for the same conditions. The site also can help expectant parents understand the importance of genetics screening, says the press release, and give them an idea of what they can expect after their baby is born. "When test results show that a baby has a health defect … early diagnosis and treatment can make the difference between lifelong disabilities and optimal development," the release notes.

Genetics Home Reference includes information on

  • genetic conditions;
  • the normal function and health effects of more than 300 genes; and
  • chromosomes, mitochondrial DNA and associated health conditions.
The site also features a handbook on understanding genetics, a glossary of terms and links to other resources.

Physicians can order free pre-printed prescription pads to "prescribe" the site to their patients. Each pad contains 50 sheets; space is provided on the pad for writing instructions. Order quantities are limited to 25 pads.

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

AAFP, USPSTF Recommend Against Routine PSA Screening

Inadequate, Disordered Sleep Increases Diabetes Risk

Text Messaging Could Hike Vaccination Rates

Fluoroquinolones Tied to Greater Retinal Detachment Risk

Sanofi Announces DTaP Vaccine Shortage

AHRQ Resources Provide Ready Access to Research Data

Community-onset C. difficile Infections on the Rise

New FamilyDoctor.org Content Helps With Caring for Elderly

U.S. Measles Cases in 2011 Highest in 15 Years

FDA Warns of More Finasteride Side Effects

'Take-Back' Initiative Focuses on Destroying Unwanted Drugs

Bariatric Surgery May Help Combat Type 2 Diabetes

Certain Skin Products Tied to Mercury Poisoning

FDA Clarifies Citalopram Usage, Dosing Warnings

Veterans With PTSD at Heightened Risk for Opioid Abuse

ACP Releases Guideline on Type 2 Diabetes Management

Office Champions Seeking Applicants for Second Wave

Surgeon General Releases Report on Teen Smoking

USPSTF Issues Final Cervical Cancer Screening Recommendations

FDA Approves First Quadrivalent Influenza Vaccine

Survey: Physicians May Have Trouble Interpreting Cancer Statistics

AIM-HI Nutrition Questionnaire Can Open Dialogue

Statin, HIV/Hepatitis C Drug Interactions May Pose Risks

Statin Therapy Effective in Both Genders, Study Suggests

AAFP, CDC Announce Immunization Schedule Change

Family Physicians on Front Lines of Caring for Vets

ACIP Votes to Expand Tdap Recommendation

Recalled Oral Contraceptives Pose Pregnancy Risk

Studies Shed Light on Vaccine Side Effect Risks

Dosing Problems Prompt Recall of Infants' Tylenol Products

TB 'Superbug' Not Stateside Threat, Says FP

Adult Vaccination Coverage Remains Low, Says CDC

FDA Warns of Health Risk Tied to PPI Use

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications